Literature DB >> 18455538

Patient-selected goal attainment for pessary wearers: what is the clinical relevance?

Yuko M Komesu1, Rebecca G Rogers, Martha A Rode, Ellen C Craig, Ronald M Schrader, Katey A Gallegos, Biatris Villareal.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate whether patient determined goal achievement is associated with pessary continuation. STUDY
DESIGN: Patients identified goals they wished to achieve from pessary use. Patients were asked whether they continued pessary use and if goals were met 6-12 months later. Goals were divided into 8 categories. Fisher exact test was used to evaluate categorical variables, t tests for continuous variables, and regression methods to calculate odds ratios (OR).
RESULTS: Eighty women enrolled in the study. Sixty-four had follow-up data. Goals commonly listed were bladder (36%), activity (20%), general health (13%), and prolapse related (11%). Thirty-four women continued and 30 discontinued pessary use. Women who continued pessary use were more likely to meet 1 or 2 goals (OR 17.5, 21.1 and 95% CI 4.8-64.4, 5.7-78.9, respectively).
CONCLUSION: Patient goals are variable and subjective. However, when assessed for achievement, they are associated with pessary continuation. Women who attain self-determined goals are likely to continue pessary use.

Entities:  

Mesh:

Year:  2008        PMID: 18455538      PMCID: PMC3623940          DOI: 10.1016/j.ajog.2007.12.033

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

1.  Defining clinically meaningful change in health-related quality of life.

Authors:  Ross D Crosby; Ronette L Kolotkin; G Rhys Williams
Journal:  J Clin Epidemiol       Date:  2003-05       Impact factor: 6.437

Review 2.  Questionnaires for women with pelvic floor disorders.

Authors:  Matthew D Barber
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-21

3.  Psychometric properties of goal-attainment scaling in the assessment of mann's time-limited psychotherapy.

Authors:  G Shefler; L Canetti; H Wiseman
Journal:  J Clin Psychol       Date:  2001-07

4.  A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse.

Authors:  R G Rogers; D Kammerer-Doak; A Villarreal; K Coates; C Qualls
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

Review 5.  Goal setting as an outcome measure: A systematic review.

Authors:  Jane Hurn; Ian Kneebone; Mark Cropley
Journal:  Clin Rehabil       Date:  2006-09       Impact factor: 3.477

6.  The new subjective medicine: taking the patient's point of view on health care and health.

Authors:  Mark Sullivan
Journal:  Soc Sci Med       Date:  2003-04       Impact factor: 4.634

7.  Validation of two global impression questionnaires for incontinence.

Authors:  Ilker Yalcin; Richard C Bump
Journal:  Am J Obstet Gynecol       Date:  2003-07       Impact factor: 8.661

8.  Pelvic floor symptom changes in pessary users.

Authors:  Yuko M Komesu; Rebecca G Rogers; Martha A Rode; Ellen C Craig; Katey A Gallegos; Angela R Montoya; Carrie D Swartz
Journal:  Am J Obstet Gynecol       Date:  2007-12       Impact factor: 8.661

9.  Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved?

Authors:  Kathie L Hullfish; Viktor E Bovbjerg; Jennifer Gibson; William D Steers
Journal:  Am J Obstet Gynecol       Date:  2002-07       Impact factor: 8.661

10.  Patient-centered goals for pelvic floor dysfunction surgery: long-term follow-up.

Authors:  Kathie L Hullfish; Viktor E Bovbjerg; William D Steers
Journal:  Am J Obstet Gynecol       Date:  2004-07       Impact factor: 8.661

View more
  9 in total

1.  Validity and reliability of patient selected goals as an outcome measure in overactive bladder.

Authors:  Rufus Cartwright; Sushma Srikrishna; Linda Cardozo; Dudley Robinson
Journal:  Int Urogynecol J       Date:  2011-01-29       Impact factor: 2.894

Review 2.  Repair of pelvic organ prolapse: what is the goal?

Authors:  Margarita M Aponte; Nirit Rosenblum
Journal:  Curr Urol Rep       Date:  2014-02       Impact factor: 3.092

3.  The effect of hydroxyquinoline-based gel on pessary-associated bacterial vaginosis: a multicenter randomized controlled trial.

Authors:  Kate V Meriwether; Rebecca G Rogers; Ellen Craig; Sean D Peterson; Robert E Gutman; Cheryl B Iglesia
Journal:  Am J Obstet Gynecol       Date:  2015-04-30       Impact factor: 8.661

4.  Goal attainment after treatment in patients with symptomatic pelvic organ prolapse.

Authors:  Mamta M Mamik; Rebecca G Rogers; Clifford R Qualls; Yuko M Komesu
Journal:  Am J Obstet Gynecol       Date:  2013-06-13       Impact factor: 8.661

5.  Sexual Function and Pessary Management among Women Using a Pessary for Pelvic Floor Disorders.

Authors:  Kate V Meriwether; Yuko M Komesu; Ellen Craig; Clifford Qualls; Herbert Davis; Rebecca G Rogers
Journal:  J Sex Med       Date:  2015-12-03       Impact factor: 3.802

6.  Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared with pessary for pelvic organ prolapse.

Authors:  Vivian W Sung; Kyle J Wohlrab; Annetta Madsen; Christina Raker
Journal:  Am J Obstet Gynecol       Date:  2016-06-16       Impact factor: 8.661

Review 7.  Pessary treatment for pelvic organ prolapse and health-related quality of life: a review.

Authors:  Babet H C Lamers; Bart M W Broekman; Alfredo L Milani
Journal:  Int Urogynecol J       Date:  2011-04-07       Impact factor: 2.894

8.  A nationwide survey concerning practices in pessary use for pelvic organ prolapse in The Netherlands: identifying needs for further research.

Authors:  Joost Velzel; Jan Paul Roovers; C H Van der Vaart; Bart Broekman; Astrid Vollebregt; Robert Hakvoort
Journal:  Int Urogynecol J       Date:  2015-06-11       Impact factor: 2.894

Review 9.  Patient-Centered Goals for Treatment of Pelvic Floor Disorders.

Authors:  Angela Dao; Gena Dunivan
Journal:  Curr Bladder Dysfunct Rep       Date:  2022-10-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.